AbelZeta
Michael Patrick is a Senior Scientist with experience in making and analyzing mice with mutations in immune system genes. Michael has worked at various prestigious organizations such as Cellular Biomedicine Group, National Institute on Aging, and National Center for Global Health and Medicine. Patrick's expertise also includes processing and analyzing DNA from clinical specimens, developing RNA-based therapies for cervical cancer, and holds a Ph.D. in Immunology from Yamaguchi University Graduate School of Medicine.
AbelZeta
1 followers
AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies.